Seeing Is Believing

Currently out of the existing stock ratings of Derik Bruin, 43 are a BUY (43.43%), 15 are a SELL (15.15%), 41 are a HOLD (41.41%).
Analyst Derik Bruin, carries an average stock price target met ratio of 78.11% that have a potential upside of 15.84% achieved within 126 days. Previously, Derik Bruin worked at BAML.
Analyst best performing recommendations are on TLIS (TALIS BIOMEDICAL CORP).
The best stock recommendation documented was for TLIS (TALIS BIOMEDICAL CORP) at 3/9/2021. The price target of $210 was fulfilled within 1 day with a profit of $18.6 (9.72%) receiving and performance score of 97.18.
Average potential price target upside